Latest Content

All from July, these 5 novel therapeutics each claimed a “first” in their category.

Constrained optimization empirically derived social risk weights that gave equal influence to subgroup performance by dual eligibility and disability in overall contract scores.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

This study links county-level social vulnerability to variation in Medicare Advantage prior authorization policies.

Accelerated approval is granted to RP1 plus nivolumab for advanced melanoma after PD-1 failure, following nail-biting FDA approval process.

Phase 3 SOLARIS found high-dose vitamin D3 added to standard chemotherapy did not significantly improve progression-free survival in metastatic CRC.

A new AHA scientific statement defines pediatric cardiogenic shock and proposes a 5-stage classification to guide diagnosis, monitoring, and escalation of care.

The authors suggest their data could reflect phlebotomy’s role as a reactive rather than sustained control measure.

MASLD was linked to higher odds of EoE and reflux-related diseases, suggesting metabolic dysfunction may contribute to esophageal disease.